These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33492488)

  • 1. Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis.
    Atiakshin D; Buchwalow I; Horny P; Tiemann M
    Histochem Cell Biol; 2021 May; 155(5):561-580. PubMed ID: 33492488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase.
    Weidner N; Horan RF; Austen KF
    Am J Pathol; 1992 Apr; 140(4):847-57. PubMed ID: 1562049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease Profile of Tumor-Associated Mast Cells in Melanoma.
    Atiakshin D; Kostin A; Buchwalow I; Samoilova V; Tiemann M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.
    Sotlar K; Horny HP; Simonitsch I; Krokowski M; Aichberger KJ; Mayerhofer M; Printz D; Fritsch G; Valent P
    Am J Surg Pathol; 2004 Oct; 28(10):1319-25. PubMed ID: 15371947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
    Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
    Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
    Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
    J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastocytosis and related disorders.
    Chiu A; Orazi A
    Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in Allergy: Is a Bone Marrow Biopsy Optional or Essential in the Evaluation of the Patient with a Suspected Mast Cell Disorder?
    Greenberger PA; Metcalfe DD
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1134-1138. PubMed ID: 30630762
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
    Zanotti R; Bonifacio M; Lucchini G; Sperr WR; Scaffidi L; van Anrooij B; Oude Elberink HN; Rossignol J; Hermine O; Gorska A; Lange M; Hadzijusufovic E; Miething C; Müller S; Perkins C; Shomali W; Elena C; Illerhaus A; Jawhar M; Parente R; Caroppo F; Solomianyi O; Zink A; Mattsson M; Yavuz AS; Panse J; Varkonyi J; Doubek M; Sabato V; Breynaert C; Vucinic V; Schug T; Hägglund H; Wortmann F; Brockow K; Angelova-Fischer I; Belloni Fortina A; Triggiani M; Reiter A; Hartmann K; Malcovati L; Gotlib J; Shoumariyeh K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Bonadonna P; Valent P
    Leukemia; 2022 Feb; 36(2):516-524. PubMed ID: 34545185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis.
    Quintás-Cardama A; Sever M; Cortes J; Kantarjian H; Verstovsek S
    Leuk Lymphoma; 2013 Sep; 54(9):1959-64. PubMed ID: 23278641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
    Sperr WR; Escribano L; Jordan JH; Schernthaner GH; Kundi M; Horny HP; Valent P
    Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mastocytosis, MCAS, and Related Disorders-Diagnosis, Classification, and Therapy.
    Niedoszytko M; Valent P; Nedoszytko B
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stromal composition of mast cell aggregates in systemic mastocytosis.
    Chiu A; Nanaji NM; Czader M; Gheorghe G; Knowles DM; Chadburn A; Orazi A
    Mod Pathol; 2009 Jul; 22(7):857-65. PubMed ID: 19396155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mast cells arise from a common circulating progenitor.
    Maaninka K; Lappalainen J; Kovanen PT
    J Allergy Clin Immunol; 2013 Aug; 132(2):463-9.e3. PubMed ID: 23582567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.